biosimilar interleukins global market report

Biosimilar Interleukins Market Worth $2.51 Billion By 2028 CAGR Of 3.9% within Forecast Period 2024-2033

Overview and Scope Biosimilar interleukins are defined as a biosimilar produced by the body's leukocytes (white blood cells). Immune reactions…

5 months ago